ARTICLE | Company News
Belarusian State University, Double Bond Pharmaceutical International AB deal
November 9, 2015 8:00 AM UTC
The Research Institute of Physical and Chemical Problems (RI PCP) at the university granted Double Bond exclusive, worldwide rights to develop and commercialize Temodex. The deal excludes Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan and Ukraine. ...